Regulation of autoimmune diabetes by non‐islet‐specific T cells — a role for the glucocorticoid‐induced TNF receptor
暂无分享,去创建一个
E. Unanue | J. Katz | J. Shimizu | S. Sakaguchi | O. Kanagawa | A. Suri
[1] N. Sarvetnick,et al. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice , 1994, The Journal of experimental medicine.
[2] D. Godfrey,et al. α/β–T Cell Receptor (TCR)+CD4−CD8− (NKT) Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10 , 1998, The Journal of experimental medicine.
[3] A. Heimberger,et al. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. , 1990, Science.
[4] R. Coffman,et al. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell- mediated immunity , 1994, The Journal of experimental medicine.
[5] E. Shevach. Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.
[6] N. Parfrey,et al. Mechanisms of complete Freund's adjuvant protection against diabetes in BB rats: induction of non-specific suppressor cells. , 1992, Autoimmunity.
[7] A. Cooke,et al. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. , 1990, Journal of autoimmunity.
[8] L. Wen,et al. Inhibition of Diabetes by an Insulin-Reactive CD4 T-Cell Clone in the Nonobese Diabetic Mouse , 1997, Diabetes.
[9] T. Saruta,et al. Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. , 1992, Journal of autoimmunity.
[10] A. Cooke,et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non‐obese diabetic mice , 1999, Parasite immunology.
[11] O. Lantz,et al. Overexpression of Natural Killer T Cells Protects Vα14-Jα281 Transgenic Nonobese Diabetic Mice against Diabetes , 1998, The Journal of experimental medicine.
[12] N. Maclaren,et al. NKT cells and type-1 diabetes and the "hygiene hypothesis" to explain the rising incidence rates. , 2002, Diabetes technology & therapeutics.
[13] R. Flavell,et al. Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. , 1998, Immunity.
[14] M. Oldstone. Viruses as therapeutic agents. I. Treatment of nonobese insulin- dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence , 1990, The Journal of experimental medicine.
[15] P. Morel,et al. Prevention of diabetes in the NOD mouse by a Th1 clone specific for a hsp60 peptide. , 2000, Journal of autoimmunity.
[16] M. Kurrer,et al. Beta cell apoptosis in T cell-mediated autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Flavell,et al. Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. , 1993, Journal of immunology.
[18] D. Greiner,et al. Prevention of Diabetes in BB/Wor Rat by Single Transfusion of Spleen Cells: Parameters That Affect Degree of Protection , 1989, Diabetes.
[19] J. Shimizu,et al. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.
[20] N. Chapman,et al. Toward Testing the Hypothesis that Group B Coxsackieviruses (CVB) Trigger Insulin-Dependent Diabetes: Inoculating Nonobese Diabetic Mice with CVB Markedly Lowers Diabetes Incidence , 2002, Journal of Virology.
[21] M. Byrne,et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.
[22] D. Loh,et al. Differences between responses of naive and activated T cells to anergy induction. , 1998, Journal of immunology.
[23] A. Cooke,et al. Cutting Edge: Interactions Through the IL-10 Receptor Regulate Autoimmune Diabetes1 , 2001, The Journal of Immunology.
[24] M. Sadelain,et al. Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy , 1990, Diabetes.
[25] K. Lafferty,et al. T-Lymphocyte Clone Specific for Pancreatic Islet Antigen , 1988, Diabetes.
[26] T. Flotte,et al. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] H. Dosch,et al. Immunological Aspects of Nutritional Diabetes Prevention in NOD Mice: A Pilot Study for the Cow's Milk–Based IDDM Prevention Trial , 1997, Diabetes.
[28] R. Coffman,et al. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.
[29] J. Miyazaki,et al. Suppression of T(h)1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10. , 2001, International immunology.
[30] D. Greiner,et al. Regulatory T cell control of autoimmune destruction of beta cells in the BB rat. , 1988, Advances in experimental medicine and biology.
[31] A. Baxter,et al. Comparison of high and low diabetes incidence non-obese diabetic mouse strains , 1989 .
[32] M. Oldstone. Prevention of type I diabetes in nonobese diabetic mice by virus infection. , 1988, Science.
[33] C. Boitard,et al. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice , 1989, The Journal of experimental medicine.
[34] E. Unanue,et al. Immune complexes inhibit antimicrobial responses through interleukin-10 production. Effects in severe combined immunodeficient mice during Listeria infection. , 1995, The Journal of clinical investigation.
[35] P. Pandolfi,et al. Role of GITR in activation response of T lymphocytes. , 2002, Blood.
[36] S. Sakaguchi. Regulatory T cells , 2000, Cell.
[37] H. Mcdevitt,et al. CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer , 2002, The Journal of experimental medicine.
[38] C. Benoist,et al. Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes , 2001, Nature Immunology.
[39] D. Greiner,et al. Depletion of RT6.1+ T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats , 1987, The Journal of experimental medicine.
[40] K. Buschard,et al. Gluten‐free diet prevents diabetes in NOD mice , 1999, Diabetes/metabolism research and reviews.
[41] Chyung-Ru Wang,et al. Cd1-Restricted Nk T Cells Protect Nonobese Diabetic Mice from Developing Diabetes , 2001, The Journal of experimental medicine.
[42] C. Benoist,et al. Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.
[43] N. Sarvetnick,et al. Mechanism underlying counterregulation of autoimmune diabetes by IL-4. , 1997, Immunity.
[44] A. Baxter,et al. High and low diabetes incidence nonobese diabetic (NOD) mice: origins and characterisation. , 1991, Autoimmunity.
[45] T. Ohsugi,et al. Increased incidence of diabetes mellitus in specific pathogen-eliminated offspring produced by embryo transfer in NOD mice with low incidence of the disease. , 1994, Laboratory animal science.
[46] A. Cooke,et al. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes , 2003, European journal of immunology.
[47] J. Miyazaki,et al. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. , 1994, International Immunology.
[48] M. Sadelain,et al. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. , 1993, Journal of immunology.
[49] C. Benoist,et al. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[50] Svetlana Ten,et al. Multiple immuno-regulatory defects in type-1 diabetes. , 2002, The Journal of clinical investigation.
[51] M. Kurrer,et al. T Helper 2 (Th2) T Cells Induce Acute Pancreatitis and Diabetes in Immune-compromised Nonobese Diabetic (NOD) Mice , 1997, The Journal of experimental medicine.
[52] C. Janeway,et al. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells , 1996, The Journal of experimental medicine.
[53] A Jaramillo,et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice , 1993, The Journal of experimental medicine.
[54] P. Betts,et al. Early infection and subsequent insulin dependent diabetes , 1997, Archives of disease in childhood.
[55] E. Unanue,et al. A T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[56] A. Baxter,et al. Comparison of High— and Low—Diabetes-Incidence NOD Mouse Strains , 1989, Diabetes.
[57] L. Orci,et al. Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes , 1992, The Journal of experimental medicine.
[58] J. Lafaille,et al. The Role of IFN-γ in the Production of Th2 Subpopulations: Implications for Variable Th2-Mediated Pathologies in Autoimmunity1 , 2001, The Journal of Immunology.
[59] C. Benoist,et al. Interleukin-4 Deficiency Does Not Exacerbate Disease in NOD Mice , 1998, Diabetes.
[60] C. Janeway,et al. Prevention of Diabetes in NOD Mice by Injection of Autoreactive T-Lymphocytes , 1989, Diabetes.
[61] N. Sarvetnick,et al. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice , 1996, The Journal of experimental medicine.
[62] H. Mcdevitt,et al. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[63] D. Wegmann,et al. Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity. , 1996, Journal of autoimmunity.
[64] O. Kanagawa,et al. Regulation of Diabetes Development by Regulatory T Cells in Pancreatic Islet Antigen-Specific TCR Transgenic Nonobese Diabetic Mice1 , 2002, The Journal of Immunology.
[65] R. Tisch,et al. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process , 1994, The Journal of experimental medicine.